Market cap
₹18 Cr
Recently Viewed
Clear AllBSE: 512217
₹30.17
₹-1.32
(-4.19%)
As on 30-Apr-2026IST
Market cap
₹18 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
30.5
P/B Ratio
1.2
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹1 Cr
ROE
-0.3 %
ROCE
-0.4 %
Industry P/E
24.25
EV/EBITDA
31.4
Debt to Equity
0
Book Value
₹25.8
EPS
₹1
Face value
10
Shares outstanding
6,063,428
CFO
₹-5.87 Cr
EBITDA
₹-0.16 Cr
Net Profit
₹-0.89 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Prism Medico
| 58.8 | 13.9 | 85.1 | 113.5 | 6.5 | 27.8 | -- |
|
BSE FMCG
| -6.3 | 12.6 | 0.8 | -7.9 | 3.1 | 8.4 | 9.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Prism Medico
| -19.2 | -17.2 | -12.2 | 210.1 | -56.5 | 31.7 | -44.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Prism Medico
|
30.2 | 18.3 | 2.2 | 0.6 | 24.3 | 4 | 30.5 | 1.2 |
| 4.2 | 72.3 | 151.0 | 4.9 | 3.0 | 5.5 | 14.7 | 0.8 | |
| 196.4 | 25,545.2 | 74,730.7 | 990.4 | 2.3 | 10.4 | 24.5 | 2.4 | |
| 596.3 | 11,468.5 | 10,232.7 | 405.0 | 6.2 | 25.9 | 24.3 | 5.6 | |
| 963.5 | 21,373.8 | 9,624.4 | 348.3 | 6.4 | 19.6 | 61.4 | 11.3 | |
| 202.5 | 647.8 | 1,663.1 | 122.6 | 9.2 | 37.8 | 5.3 | 1.8 | |
| 198.3 | 107.1 | 392.4 | 5.1 | -- | 15.8 | 21.2 | 3.3 | |
| 33.9 | 128.4 | 73.7 | 3.8 | 5.9 | 6.7 | 33.4 | 2.2 | |
| 19.8 | 10.3 | 10.1 | 1.0 | 1.3 | 9.1 | 9.9 | 0.7 | |
| 22.5 | 9.2 | 0.0 | 0.1 | -- | 2.5 | 71.4 | 1.5 |
No Review & Analysis are available.
Prism Medico and Pharmacy Limited, a non-banking finance company, engages in the business of financing in India. The company was formerly known as Woolite Mercantile Company Limited and changed its name to Prism Medico and Pharmacy Limited in January... 2012. Prism Medico and Pharmacy Limited was incorporated in 2002 and is based in Mumbai, India. Read more
Incorporated
2002
Chairman
--
Managing Director
--
Headquarters
Sirmour, Himachal Pradesh
Website
Looking for more details about Prism Medico and Pharmacy Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Prism Medico and Pharmacy Ltd is ₹30.17 (BSE) as of 30-Apr-2026 IST. Prism Medico and Pharmacy Ltd has given a return of 6.47% in the last 3 years.
The P/E ratio of Prism Medico and Pharmacy Ltd is 30.49 times as on 30-Apr-2026, a 26 premium to its peers’ median range of 24.25 times.
The P/B ratio of Prism Medico and Pharmacy Ltd is 1.17 times as on 30-Apr-2026, a 21 discount to its peers’ median range of 1.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.47
|
|
2024
|
0.00
|
1.09
|
|
2023
|
0.00
|
1.15
|
|
2022
|
0.00
|
0.37
|
|
2021
|
0.00
|
0.55
|
The 52-week high and low of Prism Medico and Pharmacy Ltd are Rs 34.49 and Rs 12.49 as of 02-May-2026.
Prism Medico and Pharmacy Ltd has a market capitalisation of ₹ 18 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Prism Medico and Pharmacy Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.